TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9423108

Group type: EXPERIMENTAL
Intervention: Propofol (2.5 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thiopentone (4 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 30
Study: 2685007

Group type: EXPERIMENTAL
Intervention: Biosynthetic human GH therapy (Norditropin; 2 IU/m2.day)
Number of subjects: 22
Study: 5067671

Group type: EXPERIMENTAL
Intervention: Hot drink of milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Horlicks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hot water
Number of subjects: 0
Study: 30989330

Group type: EXPERIMENTAL
Intervention: Bosutinib 400 mg once daily
Number of subjects: 487

Group type: COMPARATOR
Intervention: Imatinib 400 mg once daily
Number of subjects: 487
Study: 29118371

Group type: EXPERIMENTAL
Intervention: MIR137 SNP rs1625579
Number of subjects: 736

Group type: COMPARATOR
Intervention: CPLX1 expression
Number of subjects: 736

Group type: COMPARATOR
Intervention: allele and genotype frequencies of studied SNPs
Number of subjects: 736
Study: 25092775

Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 6) once every 3 weeks for four cycles
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) once every 2 weeks for nine cycles
Number of subjects: 443

Group type: COMPARATOR
Intervention: Standard neoadjuvant chemotherapy (paclitaxel followed by ddAC)
Number of subjects: 443
Study: 23114287

Group type: EXPERIMENTAL
Intervention: Exogenous creatine phosphate added to cardioplegic solution
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no creatine phosphate)
Number of subjects: 24
Study: 20810254

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with transference interpretation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Dynamic psychotherapy without transference interpretation
Number of subjects: 46
Study: 19459146

Group type: EXPERIMENTAL
Intervention: Immune-modulating nutrition (IMN) formula
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard stress formula (relative comparison group)
Number of subjects: 15
Study: 16770612

Group type: EXPERIMENTAL
Intervention: Arm exercise during pressure support ventilation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Arm exercise during trach collar (unassisted respiration)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Exercise-induced dyspnea and arm discomfort
Number of subjects: 8
Study: 15544576

Group type: EXPERIMENTAL
Intervention: TPH1 gene polymorphism (T27224C)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Three-allele haplotypes involving T27224C polymorphism
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Depression, anxiety, and comorbid depression and anxiety disorders
Number of subjects: 206
Study: 11153670

Group type: EXPERIMENTAL
Intervention: Rifabutin 300-450 mg daily
Number of subjects: 2288

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg twice daily
Number of subjects: 2288

Group type: COMPARATOR
Intervention: Combination of rifabutin and clarithromycin
Number of subjects: 2288

Group type: COMPARATOR
Intervention: No MAC prophylaxis
Number of subjects: 2288
Study: 9286780

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 infusion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Prostacyclin infusion
Number of subjects: 18
Study: 8365299

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 micrograms, Salbutamol 400 micrograms, Ipratropium Bromide 80 micrograms
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ipratropium Bromide 80 micrograms, Salbutamol 200 micrograms, Salbutamol 400 micrograms
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maximal doses of Ipratropium Bromide (80 micrograms)
Number of subjects: 9
Study: 6810527

Group type: EXPERIMENTAL
Intervention: Total orchidectomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Subcapsular orchidectomy
Number of subjects: 22
Study: 31394770

Group type: EXPERIMENTAL
Intervention: Exercise plus directed forgetting (Ex + DF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Directed forgetting only (DF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Remember only (R)
Number of subjects: 60
Study: 28115474

Group type: EXPERIMENTAL
Intervention: Insulin Glargine 300 units/mL (Gla‐300)
Number of subjects: 59
Study: 24993934

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg daily (arm A)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg plus bicalutamide 50 mg daily (arm B)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 23
Study: 24462367

Group type: EXPERIMENTAL
Intervention: Meals supplemented with 1.4 g of cocoa extract (645.3 mg of polyphenols)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control meals within a 15% energy restriction diet
Number of subjects: 50
Study: 22968185

Group type: EXPERIMENTAL
Intervention: nonsurgical approach to ground-glass nodules (GGNs)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: nonsurgical approach to part-solid GGNs (psGGNs) with solid component smaller than 5 mm
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: nonsurgical approach to part-solid GGNs (psGGNs) with solid component larger than 5 mm
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: nonsurgical approach to GGNs
Number of subjects: 56
Study: 19008862

Group type: EXPERIMENTAL
Intervention: In vivo circulating oxLDL measured in hypertensive elderly individuals
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: Hypertensive stages (low to high)
Number of subjects: 1130
Study: 17516265

Group type: EXPERIMENTAL
Intervention: Subconjunctival anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 16439238

Group type: EXPERIMENTAL
Intervention: Rectus femoris transfer surgery
Number of subjects: 40
Study: 12759107

Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg/day
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg/day
Number of subjects: 128

Group type: COMPARATOR
Intervention: Granisetron 0 mg/day (control)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: All groups treated with a 21‐mg nicotine patch
Number of subjects: 128
Study: 10585155

Group type: EXPERIMENTAL
Intervention: Affinity oxygenator with 10 ml of 25% albumin added to the pump prime (Albumin group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Trillium-coated Affinity oxygenator (Trillium group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (Albumin group)
Number of subjects: 56
Study: 8952015

Group type: EXPERIMENTAL
Intervention: Prophylactic antiepileptic drugs (AEDs)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no prophylactic AEDs)
Number of subjects: 6
Study: 2009894

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg and Diltiazem 60 mg combination
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6355056

Group type: EXPERIMENTAL
Intervention: Topical acyclovir cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical acyclovir ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (polyethylene glycol ointment and modified aqueous cream)
Number of subjects: 0
Study: 31535371

Group type: EXPERIMENTAL
Intervention: Parenting for Lifelong Health (PLH) program
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 296
Study: 31405391

Group type: EXPERIMENTAL
Intervention: Online family problem-solving therapy (OFPST)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 359
Study: 27828768

Group type: EXPERIMENTAL
Intervention: Natural Curcumin (100 mg/L)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Photogem (100 mg/L)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Natural Curcumin (25 mg/L)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Photogem (25 mg/L)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 50

Group type: COMPARATOR
Intervention: PS control
Number of subjects: 50

Group type: COMPARATOR
Intervention: Light control
Number of subjects: 50
Study: 25585083

Group type: EXPERIMENTAL
Intervention: Sacral nerve modulation ON
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sacral nerve modulation OFF
Number of subjects: 31
Study: 23539534

Group type: EXPERIMENTAL
Intervention: PH-797804 3 mg
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: PH-797804 6 mg
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: PH-797804 3 mg and 6 mg
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 21665112

Group type: EXPERIMENTAL
Intervention: Electric point stimulator type of TENS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (detuned electric point stimulator type of TENS)
Number of subjects: 60
Study: 19766947

Group type: EXPERIMENTAL
Intervention: PSUNC exposure (treatment)
Number of subjects: 1969

Group type: COMPARATOR
Intervention: No exposure (control)
Number of subjects: 1969
Study: 16412464

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12635671

Group type: EXPERIMENTAL
Intervention: dorzolamide 3 times daily for 4 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: latanoprost once daily for 4 weeks
Number of subjects: 20
Study: 10848925

Group type: EXPERIMENTAL
Intervention: Budesonide (800 microg b.d.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9176828

Group type: EXPERIMENTAL
Intervention: Pediasure with approximately 10 g total dietary fiber/l (PSF10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pediasure (PS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pediasure with fiber (PSF10)
Number of subjects: 20
Study: 1544291

Group type: EXPERIMENTAL
Intervention: 10 mg bromfenac
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 25 mg bromfenac
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 50 mg bromfenac
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 100 mg bromfenac
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 650 mg aspirin
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 280

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 280
Study: 3909375

Group type: EXPERIMENTAL
Intervention: Gluten-free diet for 16-36 months (mean, 20 months)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Non-restricted diet for 17-35 months (mean, 20 months)
Number of subjects: 41
Study: 30688501

Group type: EXPERIMENTAL
Intervention: Visual-perceptual group (temporal occlusion training)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Visuomotor group (temporal occlusion training + motor pattern practice)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 39
Study: 28440343

Group type: EXPERIMENTAL
Intervention: Sildenafil (high-dose)
Number of subjects: 85
Study: 26400818

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 50
Study: 25306234

Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 102

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 102
Study: 22801672

Group type: EXPERIMENTAL
Intervention: Escitalopram, 10 mg/d (n = 90)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo (n = 91)
Number of subjects: 181
Study: 19862667

Group type: EXPERIMENTAL
Intervention: Colesevelam hydrochloride 3.75 g/day
Number of subjects: 509
Study: 17908665

Group type: EXPERIMENTAL
Intervention: Parsonnet score
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Tu score
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Logistic regression
Number of subjects: 622
Study: 16204422

Group type: EXPERIMENTAL
Intervention: Educational video about Tourette's Syndrome (TS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Video about depression
Number of subjects: 170

Group type: COMPARATOR
Intervention: No educational video
Number of subjects: 170
Study: 11168740

Group type: EXPERIMENTAL
Intervention: Zinc citrate toothpaste with 1% triglyceride oil
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zinc citrate toothpaste with 8% triglyceride oil
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional commercial fluoride control toothpaste
Number of subjects: 24
Study: 9553537

Group type: COMPARATOR
Intervention: Compression hip screw
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Medoff sliding plate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 160
Study: 7848349

Group type: EXPERIMENTAL
Intervention: Deponit 5 (test patch)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Reference patch
Number of subjects: 37
Study: 3287884

Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 82

Group type: COMPARATOR
Intervention: Renografin
Number of subjects: 82
Study: 29643045

Group type: COMPARATOR
Intervention: 0.9-ms 1064-nm Nd:YAG laser alone
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.9-ms 1064-nm Nd:YAG laser combined with itraconazole
Number of subjects: 37
Study: 28061794

Group type: EXPERIMENTAL
Intervention: DQIP intervention (data-driven quality improvement in primary care)
Number of subjects: 0
Study: 25141907

Group type: EXPERIMENTAL
Intervention: α1‐adrenoceptor antagonists (tamsulosin)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: uroflowmetry biofeedback combined with α1‐adrenoceptor antagonists
Number of subjects: 155

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 155
Study: 23268373

Group type: EXPERIMENTAL
Intervention: ACL reconstruction patients (operated limb)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ACL reconstruction patients (non-operated limb)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Secondary task (both groups)
Number of subjects: 45
Study: 21216208

Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation at CV17
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acupuncture stimulation at CV16
Number of subjects: 14
Study: 18452256

Group type: EXPERIMENTAL
Intervention: 0.5 microg/kg remifentanil (Group II)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 microg/kg remifentanil (Group III)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (Group I)
Number of subjects: 90
Study: 16921684

Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation at 6 L/min through a Jackson Pratt drain into the pericardium during cardiopulmonary bypass
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 12943177

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Moxibustion (Mox)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (routine acupuncture therapy and ROM exercise)
Number of subjects: 35
Study: 10379478

Group type: EXPERIMENTAL
Intervention: Endoscopic polypectomies (425 total, mean of 23.6 per patient)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Presence of microadenomas
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori search
Number of subjects: 37
Study: 8829883

Group type: EXPERIMENTAL
Intervention: Lactobionate-based solutions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypertonic citrate solutions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracellular solutions
Number of subjects: 0
Study: 2072494

Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg‐1 pethidine (group 1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.7 mg.kg‐1 pethidine (group 2)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (0.5 mg.kg‐1 and 0.7 mg.kg‐1 pethidine)
Number of subjects: 22
Study: 6418905

Group type: EXPERIMENTAL
Intervention: High dose branched-chain amino acid (BcAA) hyperalimentation (45% BcAA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard amino acid solution (24.2% BcAA)
Number of subjects: 0
Study: 30935324

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham spinal manipulative therapy (sham SMT)
Number of subjects: 29
Study: 30102338

Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing of EBV-positive NPC samples
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Functional analyses of FBXO11 gene
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Assembly of full-length EBV genomes
Number of subjects: 12
Study: 27023407

Group type: EXPERIMENTAL
Intervention: Miniscrews
Number of subjects: 80
Study: 25041620

Group type: EXPERIMENTAL
Intervention: Intralesional recombinant human epidermal growth factor (rhEGF) 75 μg, thrice-per-week for 8 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 22211683

Group type: EXPERIMENTAL
Intervention: High Fat Meal with Fruit Juice Drink (HFM-FJD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High Fat Meal with Placebo (HFM-P)
Number of subjects: 14
Study: 20142693

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) thrice daily and physical therapy (PT) twice daily during hospitalization.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical therapy (PT) twice daily during hospitalization (Control group).
Number of subjects: 0
Study: 18613962

Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapies (ACT)
Number of subjects: 3174
Study: 15792396

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg once daily) alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg once daily) and telithromycin (800 mg once daily) given concomitantly
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg once daily) and clarithromycin (500 mg twice daily) given concomitantly
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Telithromycin plus ketoconazole
Number of subjects: 32
Study: 14622692

Group type: EXPERIMENTAL
Intervention: Opioids long-term
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drugs long-term
Number of subjects: 200
Study: 10499947

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 10 mg intravenous
Number of subjects: 140

Group type: COMPARATOR
Intervention: Nonakathisic intravenous therapy (saline solution or antibiotics)
Number of subjects: 140
Study: 8738691

Group type: EXPERIMENTAL
Intervention: pH-stat (n = 23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: alpha-stat (n = 22)
Number of subjects: 45
Study: 1843106

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy
Number of subjects: 0
Study: 7049587

Group type: EXPERIMENTAL
Intervention: Amiloride/hydrochlorothiazide combination (2 tablets per day of 5 mg amiloride plus 50 mg hydrochlorothiazide)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone (50 mg hydrochlorothiazide)
Number of subjects: 24
Study: 6140973

Group type: EXPERIMENTAL
Intervention: Oxypertine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 29464385

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg administered via i.v. 20 minutes before surgery completion)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Saline (1 ml administered via i.v. 20 minutes before surgery completion)
Number of subjects: 140
Study: 27305293

Group type: EXPERIMENTAL
Intervention: 8-week anger management programme followed by a 4-week psychosocial impact intervention
Number of subjects: 26

Group type: COMPARATOR
Intervention: Psychosocial adjustment programme
Number of subjects: 26
Study: 24673708

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL; 4 mg intravenously every 21-28 days)
Number of subjects: 1960

Group type: COMPARATOR
Intervention: Clodronate (CLO; 1600 mg/d orally)
Number of subjects: 1960

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 1960

Group type: COMPARATOR
Intervention: Clodronate (CLO)
Number of subjects: 1960
Study: 22798380

Group type: EXPERIMENTAL
Intervention: Performance-based measures (walking speed)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Performance-based measures (Physical Performance and Mobility Examination)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Performance-based measures (chair-rise test)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Self-reported mobility
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Self-reported strength
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Self-reported balance
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Measures of body sway
Number of subjects: 148
Study: 20835640

Group type: EXPERIMENTAL
Intervention: Open suction system (OSS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Closed suction system (CSS)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both OSS and CSS
Number of subjects: 39
Study: 18931221

Group type: EXPERIMENTAL
Intervention: Forced-air warming (Bair Hugger warming cover #300, blower #750)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Polymer fiber resistive warming (HotDog whole body blanket)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison of both systems
Number of subjects: 8
Study: 15904654

Group type: EXPERIMENTAL
Intervention: Caffeine administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14657744

Group type: EXPERIMENTAL
Intervention: Modified group with open door type of cervical en bloc laminoplasty, bone grafts placed at three levels, no grafting in hinged side, neck collar worn for 1 month, early exercise of posterior neck muscle advised.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with original operation and postoperative therapy, bone grafts from dissected spinous processes, grafts placed from three to five levels, orthosis applied for up to 1 month, neck collar recommended for 1 additional month.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 10584416

Group type: EXPERIMENTAL
Intervention: Local addition of ketoprofen (1:400) with 4 ml of 1% lidocaine
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (without ketoprofen) with 4 ml of 1% lidocaine
Number of subjects: 1000